Skip to content

Drug interactions

Methylprednisolone + Tisagenlecleucel

Severity: Major

Methylprednisolone and Tisagenlecleucel: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Corticosteroids can impair CAR-T cell expansion and persistence through lymphotoxic effects, potentially reducing efficacy, and they add to infection risk. They are nevertheless the mainstay of treatment for cytokine release syndrome and neurotoxicity.

What this interaction means in plain words

Methylprednisolone and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Methylprednisolone belongs to Endocrine; Tisagenlecleucel belongs to Oncology.

Evidence level: Moderate

Why it happens

Glucocorticoid-mediated suppression and lysis of T lymphocytes may blunt CAR-T cell activity and add to immunosuppression.

What to do

Avoid prophylactic systemic methylprednisolone as premedication before infusion. Use it for cytokine release syndrome or neurotoxicity as per protocol, and monitor for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Methylprednisolone and Tisagenlecleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Methylprednisolone with Tisagenlecleucel?

MediHelp rates the interaction as major. Methylprednisolone and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Corticosteroids can impair CAR-T cell expansion and persistence through lymphotoxic effects, potentially reducing efficacy, and they add to infection risk. They are nevertheless the mainstay of treatment for cytokine release syndrome and neurotoxicity.

How serious is the interaction between Methylprednisolone and Tisagenlecleucel?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid prophylactic systemic methylprednisolone as premedication before infusion. Use it for cytokine release syndrome or neurotoxicity as per protocol, and monitor for infection.

What other medicines interact with Methylprednisolone?

MediHelp also lists interactions of Methylprednisolone with, for example, Bcg vaccine live, Measles mumps and rubella vaccine live, Measles mumps rubella and varicella vaccine live. The full list is on the Methylprednisolone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in